Skip to main content
SD BIOSENSOR INC. logo

SD BIOSENSOR INC. — Investor Relations & Filings

Ticker · 137310 ISIN · KR7137310009 KO Manufacturing
Open in API
Filings indexed 337 across all filing types
Latest filing 2026-03-04 Proxy Solicitation & In…
Country KR South Korea
Listing KO 137310

About SD BIOSENSOR INC.

https://www.sdbiosensor.com/

SD BIOSENSOR INC. is an in-vitro diagnostics company that develops, manufactures, and supplies point-of-care (POC) diagnostic solutions. The company specializes in rapid diagnostic tests (RDTs), biosensors, and diagnostic reagents aimed at the early and accurate diagnosis, prevention, and management of diseases. A key product is the STANDARD M, a point-of-care molecular diagnostics (MDx) system designed for fast and simple clinical decision-making near the patient. Through its focus on innovative biosensor technology, the company aims to improve the quality of life by providing accessible and reliable diagnostic tools.

Recent filings

Filing Released Lang Actions
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Notice of Convocation of General Meeting of Shareholders' (주주총회소집공고) which includes detailed amendments to the Articles of Incorporation (정관 변경). This document is provided to shareholders to inform them of the meeting agenda, proposed changes, and voting items. In the context of corporate filings, such materials are classified as Proxy Solicitation & Information Statements (PSI) as they provide the necessary information for shareholders to exercise their voting rights at the upcoming meeting.
2026-03-04 Korean
[기재정정]주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal 'Notice of Convocation of General Meeting of Shareholders' (주주총회소집결의) issued by SD Biosensor. It details the agenda for an upcoming Annual General Meeting (AGM), including items such as financial statement approval, articles of incorporation amendments, and director/auditor appointments. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting details and agenda items for voting. Therefore, it falls under the Proxy Solicitation & Information Statement category.
2026-03-04 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release Classification · 1% confidence The document is a regulatory filing from a Korean company (SD Biosensor) announcing a significant change in financial results (30% or more change in revenue or profit structure). This is a standard preliminary earnings announcement (often referred to as '잠정실적' in Korea) provided to investors before the final audited financial statements are released. It contains key financial highlights, comparative data, and reasons for the change, fitting the definition of an Earnings Release (ER). FY 2025
2026-02-25 Korean
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Regulatory Filings Classification · 1% confidence The document is a regulatory announcement from SD Biosensor regarding the determination of a record date for shareholder rights in relation to cash/in-kind dividends. It is a short, formal notice of a corporate action (setting a record date for dividends) rather than the dividend payment announcement itself or a full financial report. Given the nature of the announcement regarding shareholder record dates for dividends, it falls under the category of general regulatory announcements or notices that do not fit into specific financial reporting categories.
2026-02-25 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 1% confidence The document is an official announcement from SD Biosensor regarding a decision to pay cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the payment date. This aligns perfectly with the definition of a 'Notice of Dividend Amount' (DIV).
2026-02-25 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of an upcoming Annual General Meeting (AGM) for SD Biosensor. It details the meeting date, location, agenda items (such as financial statement approval, director/auditor appointments, and articles of incorporation changes), and provides specific details on board nominations. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the meeting and request their participation/votes.
2026-02-25 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.